Free Trial

Neogen (NEOG) Competitors

Neogen logo
$5.47 -0.03 (-0.55%)
Closing price 09/15/2025 04:00 PM Eastern
Extended Trading
$5.45 -0.02 (-0.38%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NEOG vs. ICUI, XRAY, HAE, QDEL, STAA, CERS, OSUR, UTMD, ANIK, and WST

Should you be buying Neogen stock or one of its competitors? The main competitors of Neogen include ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), Haemonetics (HAE), QuidelOrtho (QDEL), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), and West Pharmaceutical Services (WST). These companies are all part of the "health care supplies" industry.

Neogen vs. Its Competitors

Neogen (NASDAQ:NEOG) and ICU Medical (NASDAQ:ICUI) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, media sentiment, institutional ownership, dividends, valuation and earnings.

ICU Medical has higher revenue and earnings than Neogen. ICU Medical is trading at a lower price-to-earnings ratio than Neogen, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Neogen$894.66M1.33-$1.09B-$5.03-1.09
ICU Medical$2.38B1.37-$117.69M-$1.52-86.95

Neogen currently has a consensus price target of $7.50, indicating a potential upside of 37.11%. ICU Medical has a consensus price target of $181.00, indicating a potential upside of 36.94%. Given Neogen's higher probable upside, research analysts clearly believe Neogen is more favorable than ICU Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Neogen
0 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.25
ICU Medical
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.00

Neogen has a beta of 1.84, meaning that its share price is 84% more volatile than the S&P 500. Comparatively, ICU Medical has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500.

96.7% of Neogen shares are held by institutional investors. Comparatively, 96.1% of ICU Medical shares are held by institutional investors. 1.1% of Neogen shares are held by company insiders. Comparatively, 1.5% of ICU Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

ICU Medical has a net margin of -1.56% compared to Neogen's net margin of -122.06%. ICU Medical's return on equity of 7.24% beat Neogen's return on equity.

Company Net Margins Return on Equity Return on Assets
Neogen-122.06% 2.39% 1.57%
ICU Medical -1.56%7.24%3.50%

In the previous week, Neogen had 18 more articles in the media than ICU Medical. MarketBeat recorded 34 mentions for Neogen and 16 mentions for ICU Medical. ICU Medical's average media sentiment score of 1.12 beat Neogen's score of 0.28 indicating that ICU Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Neogen
5 Very Positive mention(s)
1 Positive mention(s)
25 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral
ICU Medical
8 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

ICU Medical beats Neogen on 12 of the 17 factors compared between the two stocks.

Get Neogen News Delivered to You Automatically

Sign up to receive the latest news and ratings for NEOG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NEOG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NEOG vs. The Competition

MetricNeogenMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.19B$10.74B$5.80B$10.16B
Dividend YieldN/A1.86%5.72%4.60%
P/E Ratio-1.0920.5675.1326.39
Price / Sales1.3329.77508.32174.86
Price / Cash0.9525.0025.8129.91
Price / Book0.573.4313.716.28
Net Income-$1.09B$210.63M$3.29B$270.38M
7 Day Performance-4.54%-1.46%0.07%1.89%
1 Month Performance0.74%1.65%4.57%6.01%
1 Year Performance-66.52%-11.43%78.24%25.26%

Neogen Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NEOG
Neogen
3.2712 of 5 stars
$5.47
-0.5%
$7.50
+37.1%
-66.1%$1.19B$894.66M-1.092,110
ICUI
ICU Medical
4.6115 of 5 stars
$130.58
-0.5%
$179.00
+37.1%
-26.2%$3.24B$2.38B-85.9115,000Positive News
XRAY
DENTSPLY SIRONA
4.9145 of 5 stars
$14.21
-2.8%
$18.64
+31.1%
-48.5%$2.92B$3.79B-3.0014,000Positive News
HAE
Haemonetics
4.8843 of 5 stars
$54.02
-0.7%
$85.18
+57.7%
-32.5%$2.62B$1.35B16.523,023
QDEL
QuidelOrtho
4.3265 of 5 stars
$28.47
-0.7%
$39.20
+37.7%
-36.4%$1.95B$2.78B-4.356,600Positive News
STAA
STAAR Surgical
2.6511 of 5 stars
$27.69
-0.9%
$20.67
-25.4%
-14.5%$1.38B$313.90M-14.351,211
CERS
Cerus
3.0925 of 5 stars
$1.30
-2.3%
$3.50
+169.2%
-42.0%$254.96M$180.27M-13.00290News Coverage
Short Interest ↓
OSUR
OraSure Technologies
1.9114 of 5 stars
$3.25
+0.6%
$3.00
-7.7%
-27.4%$236.23M$185.83M-4.85840
UTMD
Utah Medical Products
3.0304 of 5 stars
$63.35
-0.1%
N/A-8.1%$203.24M$40.90M16.95180Positive News
ANIK
Anika Therapeutics
4.3491 of 5 stars
$8.94
flat
$18.00
+101.3%
-64.9%$128.90M$114.55M-2.15300
WST
West Pharmaceutical Services
4.9783 of 5 stars
$253.30
+1.0%
$320.71
+26.6%
-14.3%$18.03B$2.89B37.9210,600News Coverage
Positive News
Analyst Forecast

Related Companies and Tools


This page (NASDAQ:NEOG) was last updated on 9/16/2025 by MarketBeat.com Staff
From Our Partners